Format

Send to

Choose Destination
Expert Rev Vaccines. 2008 May;7(4):437-56. doi: 10.1586/14760584.7.4.437.

Monitoring the impact of vaccines postlicensure: new challenges, new opportunities.

Author information

1
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Mailstop E-05, Atlanta, GA 30333, USA. aschuchat@cdc.gov

Abstract

Although vaccines are studied intensively before licensure, insight into important aspects of vaccine performance and the effectiveness of immunization programs and policies can only be detected after vaccines enter widespread use. Now that 17 diseases are targeted for prevention through routine immunizations in the USA, reassessment of the nation's vaccine-preventable disease-monitoring efforts is appropriate. Postlicensure disease monitoring has permitted recognition of indirect protection, vaccine effectiveness of various schedules, duration of protection, health disparities, importation patterns and microbial adaptation. The investments in vaccine research, development and regulatory procedures prelicensure, as well as resources devoted to purchase, distribution and delivery of vaccines after introduction, necessitate strategic efforts to monitor the impact of large-scale use of vaccines on disease over time.

PMID:
18444891
DOI:
10.1586/14760584.7.4.437
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center